Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease
about
Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.Assessing responsiveness over time of the PROMIS® pediatric symptom and function measures in cancer, nephrotic syndrome, and sickle cell disease.Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease.Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode.Hydroxyurea and Pain History in Relation to Patient-Reported Outcomes Using PROMIS Measures and the Frequency of Assessments in Sickle Cell Disease Patients.Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease.Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease.Association between Participants' Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell DiseaseAvailability of researcher-led eHealth tools for pain assessment and management: barriers, facilitators, costs, and design
P2860
Q33876417-10424A6D-5C4A-4C63-B3DD-1EA18B113731Q38789568-5B3DE9C6-1B74-4B31-94EC-987A402CFF24Q40051627-C971FE1D-AB65-41F8-B0EA-1BE728EB844DQ46784552-2840F176-9055-4296-A1A1-1F7357B15DA0Q49306478-FF67F238-0869-4B83-BC1C-779274B249ABQ52728984-D7A4A64A-39B3-4459-889A-065B1BA24435Q52868975-CE714903-3B06-4A2A-AFFF-51FF6BBCF6D9Q55037457-120B6326-C08B-4077-B96E-AAD8299513E2Q55250719-5498D3E9-0C31-4A0D-931C-C5D4F8A61A6BQ57175438-AB23548D-EE73-4BC6-ACCC-68D11F056077Q57493694-9DD39ADC-772A-456B-81E4-8A442C7AEE94
P2860
Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Initial Evaluation of the Pedi ...... cents With Sickle Cell Disease
@ast
Initial Evaluation of the Pedi ...... cents With Sickle Cell Disease
@en
type
label
Initial Evaluation of the Pedi ...... cents With Sickle Cell Disease
@ast
Initial Evaluation of the Pedi ...... cents With Sickle Cell Disease
@en
prefLabel
Initial Evaluation of the Pedi ...... cents With Sickle Cell Disease
@ast
Initial Evaluation of the Pedi ...... cents With Sickle Cell Disease
@en
P2093
P2860
P356
P1476
Initial Evaluation of the Pedi ...... cents With Sickle Cell Disease
@en
P2093
Bryce B Reeve
Courtney D Thornburg
Darren A DeWalt
Heather E Gross
Vaughn Barry
P2860
P304
P356
10.1002/PBC.25944
P577
2016-02-19T00:00:00Z